| |
 |
|
Class Information
Number: 514/2
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai
Description: Subject matter which contains a protein or its reaction product, e.g., peptides, peptones, fibrinogen, etc., wherein the protein molecule is not degraded to the constituent amino-acids.
Sub-classes under this class:
| Class Number |
Class Name |
Patents |
| 514/14 |
12 to 15 peptide repeating units in known peptide chain |
1,115 |
| 514/13 |
16 to 24 peptide repeating units in known peptide chain |
1,152 |
| 514/19 |
2 peptide repeating units in known peptide chain |
1,319 |
| 514/12 |
25 or more peptide repeating units in known peptide chain structure |
5,587 |
| 514/18 |
3 or 4 peptide repeating units in known peptide chain |
1,594 |
| 514/17 |
5 or 6 peptide repeating units in known peptide chain |
1,070 |
| 514/16 |
7 or 8 peptide repeating units in known peptide chain |
1,047 |
| 514/15 |
9 to 11 peptide repeating units in known peptide chain |
1,374 |
| 514/9 |
Cyclopeptides |
698 |
| 514/8 |
Glycoprotein (carbohydrate containing) |
2,032 |
| 514/6 |
Heavy metal containing (e.g., hemoglobin, etc.) |
451 |
| 514/3 |
Insulin or derivative |
607 |
| 514/5 |
Iodine containing |
42 |
| 514/7 |
Phosphorus containing |
196 |
| 514/21 |
Produced by or extracted from animal tissue |
2,378 |
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7491697 |
Muteins of fibroblast growth factor 21 |
Feb. 17, 2009 |
| 7491696 |
Proteolysis resistant active VEGF |
Feb. 17, 2009 |
| 7491693 |
HDL for the treatment of stroke and other ischemic conditions |
Feb. 17, 2009 |
| 7491692 |
Methods for making and delivering Rho-antagonist tissue adhesive formulations to the injured mammalian central and peripheral nervous systems and uses thereof |
Feb. 17, 2009 |
| 7491691 |
Connective tissue stimulating peptides |
Feb. 17, 2009 |
| 7491690 |
Self-assembly and mineralization of peptide-amphiphile nanofibers |
Feb. 17, 2009 |
| 7491689 |
Compositions comprising the biologically active peptide YSL |
Feb. 17, 2009 |
| 7491396 |
Process for the preparation of hypoallergenic mosaic antigens |
Feb. 17, 2009 |
| 7491394 |
Cytotoxic factors for modulating cell death |
Feb. 17, 2009 |
| 7488717 |
Methods of inhibiting chemokine binding to chemokine receptors |
Feb. 10, 2009 |
| 7488716 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
Feb. 10, 2009 |
| 7488715 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
Feb. 10, 2009 |
| 7488714 |
Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use |
Feb. 10, 2009 |
| 7488711 |
Use of calreticulin and calreticulin fragments to inhibit endothelial cell growth and angiogenesis, and suppress tumor growth |
Feb. 10, 2009 |
| 7488710 |
SFRP and peptide motifs that interact with SFRP and methods of their use |
Feb. 10, 2009 |
| 7488478 |
Methods and compositions for treatment of inflammatory disease using cadherin-11 modulating agents |
Feb. 10, 2009 |
| 7485619 |
Antimicrobial agent |
Feb. 3, 2009 |
| 7485618 |
FGF-5 supported and binding peptides |
Feb. 3, 2009 |
| 7485617 |
Osteoinductive materials |
Feb. 3, 2009 |
| 7485616 |
Methods of investigating, diagnosing, and treating amyloidosis |
Feb. 3, 2009 |
| 7485321 |
Peyer's patch and/or M-cell targeting ligands |
Feb. 3, 2009 |
| 7485304 |
Non-toxic mucosal adjuvant |
Feb. 3, 2009 |
| 7485301 |
Methods of treating inflammatory disease using antibodies which bind GPR-9-6 |
Feb. 3, 2009 |
| 7482329 |
Single domain TDF-related compounds and analogs thereof |
Jan. 27, 2009 |
| 7482326 |
Endothelial-monocyte activating polypeptide III |
Jan. 27, 2009 |
| 7482322 |
Plexin family-like polypeptide, and uses thereof |
Jan. 27, 2009 |
| 7482320 |
Modulation of smooth muscle cell proliferation |
Jan. 27, 2009 |
| 7482319 |
Vault and vault-like carrier molecules |
Jan. 27, 2009 |
| 7482318 |
Protein kinase domain of the large subunit of herpes simplex type 2 ribonucleotide reductase (icp 10pk) has anti-apoptotic activity |
Jan. 27, 2009 |
| 7482139 |
Variants of antithrombin III |
Jan. 27, 2009 |
| 7482018 |
Use of oligomers and polymers for drug solubilization, stabilization, and delivery |
Jan. 27, 2009 |
| 7482014 |
Melanoma therapy |
Jan. 27, 2009 |
| 7482009 |
Non-anaphylactic forms of grass pollen Phl p 6 allergen and their use |
Jan. 27, 2009 |
| 7482008 |
Human T cell reactive feline protein (TRFP) isolated from house dust and uses therefor |
Jan. 27, 2009 |
| 7482002 |
Method of administering and using VEGF inhibitors for the treatment of prostate cancer |
Jan. 27, 2009 |
| 7482001 |
Method of administering and using VEGF inhibitors for the treatment of non small cell lung cancer |
Jan. 27, 2009 |
| 7479484 |
Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |
Jan. 20, 2009 |
| 7479480 |
Peptides that promote lipid efflux |
Jan. 20, 2009 |
| 7479479 |
CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
Jan. 20, 2009 |
| 7479478 |
Human parathyroid hormone modifications, preparation and use |
Jan. 20, 2009 |
| 7479283 |
Acellular pertussis vaccine comprising a combination of the 69 kDa and the filamentous haemagglutinin antigens of Bordetella pertussis |
Jan. 20, 2009 |
| 7479282 |
Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof |
Jan. 20, 2009 |
| 7479281 |
Botulinum toxin for treating postherpetic neuralgia |
Jan. 20, 2009 |
| 7479275 |
Method of administering and using VEGF inhibitors for the treatment of colorectal cancer |
Jan. 20, 2009 |
| 7479274 |
Method of administering and using VEGF inhibitors for the treatment of pancreatic carcinoma |
Jan. 20, 2009 |
| 7479273 |
Method of administering and using VEGF inhibitors for the treatment of renal cell cancer |
Jan. 20, 2009 |
| 7479272 |
Method of administering and using VEGF inhibitors for the treatment of breast cancer |
Jan. 20, 2009 |
| 7476651 |
Tryptophanyl-tRNA synthetase-derived polypeptides useful for the regulation of angiogenesis |
Jan. 13, 2009 |
| 7476650 |
Enzyme inhibition |
Jan. 13, 2009 |
| 7476649 |
Antiproliferative and antiviral proteins and peptides |
Jan. 13, 2009 |
|
|
|
